By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Prolexys Pharmaceuticals, Inc. (Formerly known as Myriad Proteomics) 

2150 West Dauntless Avenue

Salt Lake City  Utah  84116  U.S.A.
Phone: 801-303-1700 Fax: 801-303-1710


SEARCH JOBS


Industry
Biotechnology






Company News
Proteomics Study Reveals That Genes Involved in Invertebrate Longevity Have Surprising Parallels in Humans 3/13/2009 11:37:30 AM
Prolexys Pharmaceuticals, Inc. Successfully Completes Private Placement of USD 20 Million 11/5/2008 6:33:50 AM
Prolexys Pharmaceuticals, Inc. Initiates Phase 1 Study 8/29/2007 6:25:15 AM
Prolexys Pharmaceuticals, Inc. and Columbia University Researchers Publish Study on Anti-Tumor Properties of a Selective Small Molecule Anti-Tumor Agent With Novel Mechanism of Action 6/14/2007 10:23:37 AM
Prolexys Pharmaceuticals, Inc. and Collaborators Publish Data Identifying the Protein Interaction Network in Huntington's Disease 5/14/2007 11:28:54 AM
Ariadne Genomics, Inc. And Prolexys Pharmaceuticals, Inc. Partner To Deliver Advanced Pathway Analysis Tools For Pharmaceutical Research 11/17/2005 4:48:10 PM
Prolexys Pharmaceuticals, Inc. And Collaborators Publish Data Identifying The Protein Interaction Network Of Malarial Parasite 11/3/2005 11:21:29 AM
Prolexys Pharmaceuticals, Inc. Licenses Novel Anti-Cancer Compounds10/19/2005 5:12:49 PM
Prolexys Pharmaceuticals, Inc. Announces Appointment Of David L. Clark As President And CEO10/19/2005 5:12:47 PM
Prolexys Pharmaceuticals, Inc. Licenses The Prolexys Human Interactome Database To GlaxoSmithKline (GSK)10/19/2005 5:11:39 PM
12
//-->